Molybdenum cofactor deficiency is a rare inborn error of metabolism with ge
nerally severe symptoms, most often including neonatal seizures and severe
developmental delay. We describe a patient with an unusually mild form of t
he disease. Two mutations in MOCS2A (molybdenum cofactor synthesis enzyme 2
A) were identified: a single base change, 16C > T, that predicts a Q6X subs
titution on one allele and a 19G > T transversion that predicts a valine to
phenylalanine substitution, V7F, on the second. It is postulated that the
milder clinical symptoms result from a low level of residual molybdopterin
synthase activity derived from the 19G > T allele. (C) 2001 Wiley-Liss, Inc
.